Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NanoSerum Hemp is a hemp-derived transdermal product developed by NanoSphere Health Sciences and marketed under the Evolve Formulas brand. The product utilizes the proprietary NanoSphere Delivery System, which nano-encapsulates cannabinoids (active ingredients derived from hemp) within lipid membranes to facilitate transdermal delivery through the skin and directly into the bloodstream. This nanotechnology-based delivery system is designed to bypass the digestive system and first-pass metabolism, aiming to provide rapid and localized relief for pain and inflammation, as well as systemic therapeutic effects for conditions such as anxiety. The active cannabinoids interact with the Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2) of the endocannabinoid system. NanoSerum Hemp is classified as a hemp-derived nutraceutical supplement rather than an FDA-approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NanoSerum Hemp.